Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Autologous Dendritic Cells Pulsed with MART-1 |
Synonyms | |
Therapy Description |
Autologous Dendritic Cells Pulsed with MART-1 consists of dendritic cells pulsed with a peptide vaccine against melanocyte differentiation antigen Melan-A (MART-1), which may enhance the humoral and cytotoxic immune responses against tumor cells expressing Melan-A (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Autologous Dendritic Cells Pulsed with MART-1 | Autologous Dendritic Cells Pulsed with MART-1 consists of dendritic cells pulsed with a peptide vaccine against melanocyte differentiation antigen Melan-A (MART-1), which may enhance the humoral and cytotoxic immune responses against tumor cells expressing Melan-A (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02334735 | Phase II | Poly ICLC Autologous Dendritic Cells Pulsed with MART-1 NY-ESO-1 peptide vaccine | A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence | Completed | USA | 0 |